The effect of oxycodone on postoperative nausea and vomiting of patients undergoing laparoscopic hysterectomy

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1800017520

Enrollment

Unknown

Registered

2018-08-02

Start date

2018-08-02

Completion date

Unknown

Last updated

2018-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myoma

Interventions

control group :use sufentanil

Experimental group:use oxycodone

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Patients undergoing laparoscopic hysterectomy.

Exclusion criteria

Exclusion criteria: Patients refusal, patients with heart disease or pulmonary disease, patients who has allergy to opioids

Design outcomes

Primary

Measure	Time frame
times of nausea and vomiting;	—

Secondary

Measure	Time frame
VAS score;total amount of opioid;	—

Countries

China

Contacts

Public ContactBingdong Tao

Shengjing Hospital

sdream@vip.163.com+86 18940255594

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026